Why the study?
Does circulating natriuretic peptide testing accurately diagnose left ventricular systolic dysfunction in patients at risk for heart failure?
Population
Patients at risk of or suspected of having heart failure or left ventricular systolic dysfunction (LVSD)
Comparison
Circulating natriuretic peptides testing vs Standard clinical assessment, electrocardiogram…
Design
Review
Authors
Loading...
May support targeted LVSD screening in high-risk groups; leaves open whether it reduces echocardiography reliance pending prospective validation.
Does circulating natriuretic peptide testing accurately diagnose left ventricular systolic dysfunction in patients at risk for heart failure?
Circulating natriuretic peptides (BNP and NT-proBNP) represent a promising, non-invasive blood test for screening and diagnosing left ventricular systolic dysfunction, potentially reducing the reliance on echocardiography.
Talwar et al. (2000) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: